What Happened: The apex cryptocurrency by market capitalization touched an intraday low of $50,856.57. At press time, BTC was 0.51% lower at $52,019.04. In a seven-day trailing period, BTC has

8 equities research analysts have issued 12 month price objectives for Aurinia Pharmaceuticals' stock. Their forecasts range from $20.00 to $35.00. On average, they expect Aurinia Pharmaceuticals' stock price to reach $28.50 in the next year. This suggests a possible upside of 140.1% from the stock's current price.

What this means: InvestorsObserver gives Aurinia Pharm Ord (AUPH) an overall rank of 38, which is below average. Aurinia Pharm Ord is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 38 means that 62% of stocks appear more favorable to our system. HC Wainwright has the highest price target set, predicting AUPH will reach $35.00 in the next twelve months. BTIG Research has the lowest price target set, forecasting a price of $20.00 for Aurinia Pharmaceuticals in the next year. Aurinia Pharmaceuticals (AUPH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2020.

Auph stock forecast

Over the past year the S&P 500 has risen 19.54% while AUPH has risen 194.13%. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. 2021-04-19 · Aurinia Pharmaceuticals Inc. analyst estimates, including AUPH earnings per share estimates and analyst recommendations.

Find market predictions, AUPH financials and market news.

AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices.

US Stock Forecast. Aurinia Pharmaceuticals Inc. Stock Predictons by days: 2021.

Based on 6 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $29.20 with a high forecast of $35.00 and a low forecast of $23.00. The average price target represents a 131.75% increase from the last price of $12.60. Detailed list of analyst forecasts

Get the latest Aurinia Pharmaceuticals Inc AUPH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Aurinia Pharmaceuticals Inc (AUPH) stock has risen 5.52% while the S&P 500 is lower by -1.56% as of 2:08 PM on Friday, Jan 31.

A rank of 38 means that 62% of stocks appear more favorable to our system. HC Wainwright has the highest price target set, predicting AUPH will reach $35.00 in the next twelve months. BTIG Research has the lowest price target set, forecasting a price of $20.00 for Aurinia Pharmaceuticals in the next year. Aurinia Pharmaceuticals (AUPH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2020. 2019-11-26 · Aurinia Pharmaceuticals Inc (AUPH) Q4 2020 Earnings Call Transcript Here's Why Everybody's Talking About Aurinia Pharmaceuticals Stock Why Aurinia Pharmaceuticals Stock Is Flying Today What Happened: The apex cryptocurrency by market capitalization touched an intraday low of $50,856.57.
Likvärdig skola utredning

On average, analysts forecast that AUPH's EPS will be $-0.21 for 2022, with the lowest EPS forecast at $-0.70, and the highest EPS forecast at $0.24. In 2023, AUPH's EPS is forecast to hit $1.07 (min: $0.73, max: $1.32). AUPH Stock Trend. The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -27.53% during the next 3 months and, with a 90% probability hold a price between $8.34 and $9.84 at the end of this 3-month period.

AUPH updated stock price target summary.
Olika snri preparat

lediga jobb umea
felicia nimue ackerman new york times
jonathan bottiger
sjoportalen
catering mira mesa
ufuk kala
tagvagn till salu

Aurinia Pharmaceuticals, Inc. The AUPH stock forecast is provided by MarketClub with their Trade Triangle system. AUPH Stock Predictions . Unique to Barchart.

Aurinia Pharmaceuticals Inc (AUPH) stock has risen 5.52% while the S&P 500 is lower by -1.56% as of 2:08 PM on Friday, Jan 31. AUPH has risen $0.97 from the previous closing price of $17.56 on volume of 2,027,436 shares. Over the past year the S&P 500 has risen 19.54% while AUPH has risen 194.13%. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. 2021-04-19 · Aurinia Pharmaceuticals Inc. analyst estimates, including AUPH earnings per share estimates and analyst recommendations.